Vaccine

More Accessible COVID-19 Technology on the Horizon: The National Institute of Health Licenses its COVID-19 Tech Patents to the WHO and the Medicines Patent Pool

How IP Waivers Can Help Manage the Omicron Strain

2021 IP Year in Review

Phone, Wallet, Keys…Vaccine Passport? Canada’s Response to the Vaccine Passport Debate

Biden Support for Covid-19 Intellectual Property Waiver: A Step Below Progress?

Are Intellectual Property Rights Hindering the COVID-19 Vaccine Manufacturing Potential?

Compulsory Licensing: A Potential Tool to Increase Vaccine Supply in Canada?

TRIPS: A Barrier to Covid-19 Vaccine Access?

War or Co-operation: Implications of COVID-19 Vaccine Patents

IP Regimes May Delay a Timely Delivery of New COVID-19 Vaccines